SenesTech Signs Wilco Distributing for Evolvetm and ContraPest® Distribution in Agriculture and Professional Rodent Pest Management Market

PHOENIX, March 26, 2024 /PRNewswire/ -- SenesTech, Inc. (Nasdaq: SNES; "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations, today announces a signed distribution agreement with Wilco Distributors Inc., a distributor of pest management baits and tools to the rodent pest management market. Wilco Distributors will be a stocking distributor for Evolvetm soft bait and has placed its initial multi-pallet stocking order.

Joel Fruendt, SenesTech's President and CEO, said: "Pest management professionals and homeowners are seeking alternatives to traditional lethal methods and poisons, as poisons are highly regulated and are tricky to use without contamination, and traps are expensive and time-consuming to maintain. There is strong evidence that the addition of fertility control to an integrated pest management program increases efficacy and reduces the reliance on poison. We are particularly pleased to be partnering with Wilco Distributors, as they have a clear commitment to finding innovative and responsible products for rodent pest management, and a strong position in the Agriculture space."

Blake Hazen, Wilco Distributors' President, added, "Our mission is to manufacture and distribute quality rodent control products, both for homeowners and professionals, providing effective and efficient solutions and excellent customer service. SenesTech's fertility control products fit extremely well into our portfolio, and we are excited to introduce our customers to Evolve and ContraPest. We already have products in stock and we are fulfilling initial orders."

ContraPest and Evolve address the fundamental issue of rodent overpopulation by focusing on the rapid reproduction of rats -- controlling the population by reducing or eliminating the fertility of rats, rather than trying to keep up with the growing numbers of an infestation with poisons alone. The active ingredients in ContraPest and Evolve effectively reduced fertility in rodents in numerous independent studies. They are highly palatable to rats, easy to deploy, and offer diverse placement in many different environments.

The rodent pest control market represents a significant market opportunity. Rodents are responsible for destroying nearly 20% of the world's stored food supply due to consumption and contamination, are a vector for disease, and create $27 billion of infrastructure damage in the U.S. alone. It has been estimated that rodent pest management product sales are over $1 billion per annum and are growing. At the same time, regulators are putting more restrictions on the application of commonly used poisons, in California and elsewhere, leading pest managers to seek new methods for control.

About SenesTech
We are committed to improving the health of the world by humanely managing animal pest populations, applying our expertise in fertility control. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households ? with a product designed to be humane, effective and sustainable.

For more information visit https://senestech.com/ and https://contrapeststore.com. 

Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Poppe Enterprises' market presence and knowledge will mean immediate penetration of the Evolve product and our belief that the grain market represents a significant opportunity for Evolve.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the impacts and implications of the COVID-19 pandemic, the successful commercialization of our products, market acceptance of our products, regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2022. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

CONTACT: 
Investors:
Robert Blum, Lytham Partners, LLC,
602-889-9700, [email protected]

Company:
Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,
928-779-4143 x825

SOURCE SenesTech, Inc.